<- Go Home
Whitehawk Therapeutics, Inc.
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Market Cap
$194.7M
Volume
544.5K
Cash and Equivalents
$34.8M
EBITDA
-$122.7M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-$91.0M
Profit Margin
N/A
52 Week High
$4.48
52 Week Low
$1.55
Dividend
N/A
Price / Book Value
2.35
Price / Earnings
-2.36
Price / Tangible Book Value
2.35
Enterprise Value
$71.7M
Enterprise Value / EBITDA
-0.58
Operating Income
-$122.7M
Return on Equity
68.54%
Return on Assets
-42.46
Cash and Short Term Investments
$123.0M
Debt
N/A
Equity
$116.2M
Revenue
N/A
Unlevered FCF
N/A
Sector
Biotechnology
Category
N/A